Login / Signup

Characterization of long-term outcomes for pediatric patients with epithelioid hemangioma.

Kevin X LiuEileen M DugganAlyaa Al-IbraheemiRaja ShaikhDenise M Adams
Published in: Pediatric blood & cancer (2018)
Epithelioid hemangioma (EH) is a rare benign vascular tumor that occurs in soft tissues and bone and presents between the third and sixth decades of life. Little is known about the clinical course and outcomes of pediatric EH. We report 11 patients diagnosed with EH at a median age of 14.4 years. One patient treated with interferon and one with sirolimus exhibited partial response for >2 years. Although a benign neoplasm, EH is difficult to manage without standard protocols and portends considerable morbidity. Our findings suggest medical management, particularly sirolimus, may benefit these patients; however, long-term follow-up is needed.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • healthcare
  • prognostic factors
  • type diabetes
  • skeletal muscle
  • immune response
  • bone mineral density
  • low grade